Australia's Argent BioPharma rises on partnership with ECCPharm

Argent BioPharma

05/03/2025 01:07

** Shares of Argent BioPharma RGT.AX rise 24.1% to A$0.180

** Drug discovery firm says it has entered a strategic manufacturing partnership with ECCPharm

** Under the deal, ECCPharm will manufacture and batch release co’s cannabinoid therapies

** Trade vols at 3x the 30-day avg of 33,207 shares

** RGT up 5.9% YTD

 (Reporting by Adwitiya Srivastava in Bengaluru)

 ((Adwitiya.Srivastava@thomsonreuters.com))